Efficacy and safety of fexuprazan, a novel potassium-competitive acid blocker, compared to esomeprazole in patients with erosive esophagitis: Phase 3, non-inferiority randomized controlled trial
NEUROGASTROENTEROLOGY AND MOTILITY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要